R. Andracco

ABS0436 APREMILAST VS ADALIMUMAB EFFECTIVENESS IN BIOLOGIC-NAIVE PsA

C. Castellani, Olga Addimanda, M. Reta, Mauro Magnani et autres

Background: Both Apremilast (APR) and Adalimumab (ADA) are well known therapeutical strategies for the management of psoriatic arthritis (PsA) [1]. There are no direct effectiveness (i.e. survival rates) comparison between such therapies in biologic-naïve PsA patients. Objectives: To compare APR and ADA …

us, it (code pays fourni par la source)

ABS0668 MULTICENTER OBSERVATIONAL STUDY ON THE EFFICACY OF GUSELKUMAB IN PSORIATIC ARTHRITIS

Alberto Lo Gullo, Silvia Parisi, A. Becciolini, Marino Paroli et autres

Background: Guselkumab (GUS) is an interleukin IL-23 inhibitor which has been proven effective in treating patients with psoriatic arthritis (psA). Objectives: The purpose of this study was to determine the efficacy of GUS to obtain remission or low disease activity (LDA) in …

it, us (code pays fourni par la source)

Multicenter observational study on the efficacy of selective Janus Kinase-1 inhibitor upatacitinib in rheumatoid arthritis

Alberto Lo Gullo, Simone Parisi, Andrea Becciolini, Marino Paroli et autres

BACKGROUND: Upadacitinib (UPA) is a selective, reversible Janus kinase inhibitor (JAKi) approved for the treatment of RA. However, there is still no solid evidence on the long-term efficacy of UPA in treated patients. The purpose of this study was to determine the …

it, us (code pays fourni par la source)

POS0604 JAKi’S SURVIVAL RATE AND PREDICTORS OF DISCONTINUATION IN A COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS

Maddalena Larosa, Andrea Becciolini, Silvia Parisi, E. DI Donato et autres

it (code pays fourni par la source)

AB0595 DIFFERENCES BETWEEN SELECTIVE AND UNSELECTIVE JAKi: RESULTS FROM A MULTICENTRIC, REAL LIFE STUDY CARRIED OUT ON PATIENTS WITH RA

Maddalena Larosa, Dario Camellino, A. Becciolini, E. DI Donato et autres

it (code pays fourni par la source)

AB0302 DISCONTINUATION RATE AND PREDICTORS OF JAKI DISCONTINUATION IN A REAL LIFE COHORT: RESULTS FROM A MULTICENTRIC ITALIAN STUDY ON 864 PATIENTS WITH RA

Maddalena Larosa, Alarico Ariani, Dario Camellino, Andrea Becciolini et autres

it, us (code pays fourni par la source)

AB0386 DIFFERENCES BETWEEN JAKIS-NAIVE AND JAKIS-NOT NAIVE PATIENTS IN A REAL LIFE CLINICAL SETTING: DATA FROM AN PROSPECTIVE MULTICENTRIC ITALIAN STUDY.

Maddalena Larosa, Andrea Becciolini, Elena Bravi, Dario Camellino et autres

it (code pays fourni par la source)

AB1101 THERAPEUTIC EFFECTS OF APREMILAST ON ENTHESITIS AND DACTYLITIS IN REAL CLINICAL SETTING: AN ITALIAN MULTICENTER STUDY

Alberto Lo Gullo, Andrea Becciolini, Simone Parisi, P. Del Medico et autres

Background To date only few real-world setting studies evaluated apremilast efficacy in psoriatic arthritis (PsA). Enthesitis and dactylitis are difficult-to-treat features of PsA leading to disability and affecting quality of life. Objectives The aims of this study is to evaluate the leed …

it (code pays fourni par la source)

POS1027 APREMILAST EFFICACY IN REAL WORLD SETTINGS: RESULTS FROM AN ITALIAN MULTI-CENTER OBSERVATIONAL STUDY.

Alarico Ariani, Simone Parisi, P. Del Medico, A. Farina et autres

it (code pays fourni par la source)